Singapore Becoming Biomed Capital With Full Package Of R&D Services
This article was originally published in PharmAsia News
Executive Summary
Biomedical research and development has become a cornerstone of Singapore's economy as it continues to attract global drug makers to its "Biopolis" of towers carrying such names as Genome and Synapse.